ESMO Asia Virtual Oncology Week 2021

ESMO Asia Virtual Oncology Week 2021

ESMO Asia Virtual Oncology Week 2021

The ESMO Asia Virtual Oncology Week 2021 will be held this year in place of the ESMO Asia 2021 congress, which has been postponed to 2022. The program will be composed of several virtual events and discussions on the latest advances covering important cancer types relevant to the Asia Pacific region.


Boehringer Ingelheim is dedicated to collaborating with the oncology community on a shared journey to deliver innovative treatments for patients with cancer. At the virtual event, we will be hosting a symposium on the latest treatment options for patients with advanced/metastatic NSCLC.

Wednesday 17 November – Tuesday 23 November 2021
Virtual format

Industry Satellite Symposium

Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC

Engage with our panel of esteemed medical experts—Darren Lim, Caicun Zhou, Miura Satoru, and Chen Chung-Yu—as they provide their insight on emerging treatment strategies for advanced NSCLC in Asia. The discussions will focus on topics such as strategic approaches to NSCLC, uncommon EGFR mutations, and the role of EGFR-TKI treatment in squamous NSCLC.

Boehringer Ingelheim will be hosting this symposium on Friday, November 19, 2021 at 12:00-13:30 SGT. Registration for this virtual event is complimentary; please visit the ESMO Asia Virtual Oncology Week 2021 website to access more details by following the industry sessions included in this year’s program.

ESMO Asia 2021 Symposium Speakers

Find out more about other oncology events

Click here to find out more about other oncology meetings, congresses, symposia and activities sponsored by Boehringer Ingelheim.

© 2021 Boehringer Ingelheim International GmbH. All rights reserved.


Page last updated: November 2021